Literature DB >> 31953305

Composition-function analysis of HDL subpopulations: influence of lipid composition on particle functionality.

Katrin Niisuke1, Zsuzsanna Kuklenyik2, Katalin V Horvath1, Michael S Gardner2, Christopher A Toth2, Bela F Asztalos3.   

Abstract

The composition-function relationship of HDL particles and its effects on the mechanisms driving coronary heart disease (CHD) is poorly understood. We tested the hypothesis that the functionality of HDL particles is significantly influenced by their lipid composition. Using a novel 3D-separation method, we isolated five different-sized HDL subpopulations from CHD patients who had low preβ-1 functionality (low-F) (ABCA1-dependent cholesterol-efflux normalized for preβ-1 concentration) and controls who had either low-F or high preβ-1 functionality (high-F). Molecular numbers of apoA-I, apoA-II, and eight major lipid classes were determined in each subpopulation by LC-MS. The average number of lipid molecules decreased from 422 in the large spherical α-1 particles to 57 in the small discoid preβ-1 particles. With decreasing particle size, the relative concentration of free cholesterol (FC) decreased in α-mobility but not in preβ-1 particles. Preβ-1 particles contained more lipids than predicted; 30% of which were neutral lipids (cholesteryl ester and triglyceride), indicating that these particles were mainly remodeled from larger particles not newly synthesized. There were significant correlations between HDL-particle functionality and the concentrations of several lipids. Unexpectedly, the phospholipid:FC ratio was significantly correlated with large-HDL-particle functionality but not with preβ-1 functionality. There was significant positive correlation between particle functionality and total lipids in high-F controls, indicating that the lipid-binding capacity of apoA-I plays a major role in the cholesterol efflux capacity of HDL particles. Functionality and lipid composition of HDL particles are significantly correlated and probably both are influenced by the lipid-binding capacity of apoA-I.

Entities:  

Keywords:  high density lipoprotein; lipid ratios; phospholipids; pre-beta

Mesh:

Substances:

Year:  2020        PMID: 31953305      PMCID: PMC7053829          DOI: 10.1194/jlr.RA119000258

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  26 in total

1.  High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study.

Authors:  Bela F Asztalos; L Adrienne Cupples; Serkalem Demissie; Katalin V Horvath; Caitlin E Cox; Marcelo C Batista; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-23       Impact factor: 8.311

2.  Effect of Targeting Inflammation With Salsalate: The TINSAL-CVD Randomized Clinical Trial on Progression of Coronary Plaque in Overweight and Obese Patients Using Statins.

Authors:  Thomas H Hauser; Ninad Salastekar; Ernst J Schaefer; Tanvi Desai; Harvey L Goldfine; Kristen M Fowler; Griffin M Weber; Francine Welty; Melvin Clouse; Steven E Shoelson; Allison B Goldfine
Journal:  JAMA Cardiol       Date:  2016-07-01       Impact factor: 14.676

3.  Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.

Authors:  Laurent Camont; Marie Lhomme; Fabiana Rached; Wilfried Le Goff; Anne Nègre-Salvayre; Robert Salvayre; Catherine Calzada; Michel Lagarde; M John Chapman; Anatol Kontush
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-03       Impact factor: 8.311

4.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

5.  A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids.

Authors:  M Navab; S Y Hama; G P Hough; G Subbanagounder; S T Reddy; A M Fogelman
Journal:  J Lipid Res       Date:  2001-08       Impact factor: 5.922

6.  Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease.

Authors:  B F Asztalos; P S Roheim; R L Milani; M Lefevre; J R McNamara; K V Horvath; E J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

7.  Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial.

Authors:  Bela F Asztalos; Dorothea Collins; L Adrienne Cupples; Serkalem Demissie; Katalin V Horvath; Hanna E Bloomfield; Sander J Robins; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-25       Impact factor: 8.311

8.  Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy.

Authors:  C M Ballantyne; J A Herd; L L Ferlic; J K Dunn; J A Farmer; P H Jones; J R Schein; A M Gotto
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

9.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Authors:  D J Gordon; J L Probstfield; R J Garrison; J D Neaton; W P Castelli; J D Knoke; D R Jacobs; S Bangdiwala; H A Tyroler
Journal:  Circulation       Date:  1989-01       Impact factor: 29.690

10.  Simultaneous Quantification of Free Cholesterol, Cholesteryl Esters, and Triglycerides without Ester Hydrolysis by UHPLC Separation and In-Source Collision Induced Dissociation Coupled MS/MS.

Authors:  Michael S Gardner; Lisa G McWilliams; Jeffrey I Jones; Zsuzsanna Kuklenyik; James L Pirkle; John R Barr
Journal:  J Am Soc Mass Spectrom       Date:  2017-08-11       Impact factor: 3.109

View more
  4 in total

1.  High-density lipoprotein cholesterol efflux capacity and incidence of coronary artery disease and cardiovascular mortality: a systematic review and meta-analysis.

Authors:  Holger Thiele; Petra Buettner; Wenke Cheng; Maciej Rosolowski; Julia Boettner; Steffen Desch; Alexander Jobs
Journal:  Lipids Health Dis       Date:  2022-05-28       Impact factor: 4.315

Review 2.  HDL functionality in type 1 and type 2 diabetes: new insights.

Authors:  M John Chapman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-04-01       Impact factor: 3.243

Review 3.  High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives.

Authors:  Maria Pia Adorni; Nicoletta Ronda; Franco Bernini; Francesca Zimetti
Journal:  Cells       Date:  2021-03-05       Impact factor: 7.666

4.  Effect of metformin on the high-density lipoprotein proteome in youth with type 1 diabetes.

Authors:  Evgenia Gourgari; Kristen J Nadeau; Laura Pyle; Martin P Playford; Junfeng Ma; Nehal N Mehta; Alan T Remaley; Scott M Gordon
Journal:  Endocrinol Diabetes Metab       Date:  2021-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.